APA (7th ed.) Citation

Xia, Z., Dong, Y., Zhang, X., Xia, W., Wang, H., Zhou, Y., . . . Zhang, C. (2026). An Integrated Immunometabolic Signature Predicts Prognosis and Immunotherapy Response in ccRCC and Identifies UCN -Mediated Immune Evasion as a Therapeutic Vulnerability: Evidence from In Vitro and In Vivo Studies. Cancers, 18(9), 1373. https://doi.org/10.3390/cancers18091373

Chicago Style (17th ed.) Citation

Xia, Zhinan, et al. "An Integrated Immunometabolic Signature Predicts Prognosis and Immunotherapy Response in CcRCC and Identifies UCN -Mediated Immune Evasion as a Therapeutic Vulnerability: Evidence from In Vitro and In Vivo Studies." Cancers 18, no. 9 (2026): 1373. https://doi.org/10.3390/cancers18091373.

MLA (9th ed.) Citation

Xia, Zhinan, et al. "An Integrated Immunometabolic Signature Predicts Prognosis and Immunotherapy Response in CcRCC and Identifies UCN -Mediated Immune Evasion as a Therapeutic Vulnerability: Evidence from In Vitro and In Vivo Studies." Cancers, vol. 18, no. 9, 2026, p. 1373, https://doi.org/10.3390/cancers18091373.